311 related articles for article (PubMed ID: 19285271)
1. Risk stratification for cancer-associated venous thromboembolism.
Connolly GC; Khorana AA
Best Pract Res Clin Haematol; 2009 Mar; 22(1):35-47. PubMed ID: 19285271
[TBL] [Abstract][Full Text] [Related]
2. Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score.
Connolly GC; Khorana AA
Thromb Res; 2010 Apr; 125 Suppl 2():S1-7. PubMed ID: 20433985
[TBL] [Abstract][Full Text] [Related]
3. Identifying cancer patients at risk for venous thromboembolism.
Sousou T; Khorana A
Hamostaseologie; 2009 Jan; 29(1):121-4. PubMed ID: 19151861
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated thrombosis.
Sood SL
Curr Opin Hematol; 2009 Sep; 16(5):378-85. PubMed ID: 19606029
[TBL] [Abstract][Full Text] [Related]
5. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.
Khorana AA; Francis CW; Culakova E; Kuderer NM; Lyman GH
Cancer; 2007 Nov; 110(10):2339-46. PubMed ID: 17918266
[TBL] [Abstract][Full Text] [Related]
6. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
Khorana AA
Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
Sud R; Khorana AA
Thromb Res; 2009; 123 Suppl 4():S18-21. PubMed ID: 19303497
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, risk and outcomes of venous thromboembolism in cancer.
Falanga A; Russo L
Hamostaseologie; 2012; 32(2):115-25. PubMed ID: 21971578
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
Khorana AA; Francis CW; Culakova E; Lyman GH
Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
[TBL] [Abstract][Full Text] [Related]
10. Clinical roundtable monograph. The oncologist's role in management of venous thromboembolism.
Liebman H; Khorana A; Kessler C
Clin Adv Hematol Oncol; 2011 Jan; 9(1):suppl 1-15. PubMed ID: 21361081
[TBL] [Abstract][Full Text] [Related]
11. Treatment of venous thromboembolism in cancer patients.
Lee AY
Best Pract Res Clin Haematol; 2009 Mar; 22(1):93-101. PubMed ID: 19285276
[TBL] [Abstract][Full Text] [Related]
12. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.
Cohen AT; Alikhan R; Arcelus JI; Bergmann JF; Haas S; Merli GJ; Spyropoulos AC; Tapson VF; Turpie AG
Thromb Haemost; 2005 Oct; 94(4):750-9. PubMed ID: 16270626
[TBL] [Abstract][Full Text] [Related]
13. [Venous thromboembolism and cancer].
Descourt R; Jezequel P; Couturaud F; Leroyer C; Girard P
Rev Pneumol Clin; 2008 Dec; 64(6):282-9. PubMed ID: 19084207
[TBL] [Abstract][Full Text] [Related]
14. The incidence and risk of venous thromboembolism associated with cancer and nonsurgical cancer treatment.
Falanga A
Cancer Invest; 2009 Jan; 27(1):105-15. PubMed ID: 19160098
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
Wun T; White RH
Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
[TBL] [Abstract][Full Text] [Related]
16. [Place of cancer among the risk factors in venous thromboembolism].
Descourt R; Righini M; Carrier M; Le Gal G
Pathol Biol (Paris); 2008 Jun; 56(4):178-83. PubMed ID: 18325691
[TBL] [Abstract][Full Text] [Related]
17. Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
Pabinger I; Ay C
Hamostaseologie; 2012; 32(2):132-7. PubMed ID: 21822526
[TBL] [Abstract][Full Text] [Related]
18. Risk assessment models for cancer-associated venous thromboembolism.
Dutia M; White RH; Wun T
Cancer; 2012 Jul; 118(14):3468-76. PubMed ID: 22086826
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
Prandoni P; Samama MM
Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
[TBL] [Abstract][Full Text] [Related]
20. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
